Biospace Med is changing its name to Eos Imaging, effective immediately, in an effort to capitalize on the name recognition of its flagship low-dose imaging device.
The Paris-based company, which has its U.S. headquarters in Cambridge, Mass., makes a full-body, low-radiation X-ray workstation called the EOS ultra-low-dose 2D/3D orthopedic imaging system.
CEO Marie Meynadier said the re-branding is aimed at leveraging "the tremendous goodwill and name recognition that we have achieved in Europe and North America," according to a press release.
The company won 510(k) clearance for a pediatric version of the device in March from the Food & Drug Administration. A month later it reeled in $18 million from a group of investors to fund an expanded marketing push.
